Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Steven Klosk Insider Profile
4 Followers
Steven Klosk, President & CEO, Director at Cambrex, holds 49.57K shares in Lisata Therapeutics (Ticker: LSTA), holds 0.00 shares in Cambrex (Ticker: CBM).
Profitable Transactions
9 out of 33 Profitable Transactions
Average Return
-12.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Steven Klosk holds in companies
Most Profitable Insider Trade
Stock:
Cambrex
(CBM)
(CBM)
Rating:Informative Buy
Date:Jun 12, 2018 - Jun 12, 2019
Return:+37.50%
The most profitable trade made by Steven Klosk
Steven Klosk's Trading History
Cambrex
Dec 05, 2019
―
Uninformative Buy
―
$0.00
Lisata Therapeutics
Jan 11, 2024
Director
Uninformative Buy
―
$131.21K
List of latest transactions for each holding click on a transaction to see Steven Klosk's performance on stock
You May Also Like
Steven Klosk insider profile FAQ
What is the percentage of profitable transactions made by Steven Klosk?
The percentage of profitable transactions made by Steven Klosk is 27%.
What is the average return per transaction made by Steven Klosk?
The average return per transaction made by Steven Klosk is -12.40%.
What stocks does Steven Klosk hold?
Steven Klosk holds: CBM, LSTA stocks.
What was Steven Klosk’s latest transaction?
Steven Klosk latest transaction was an Uninformative Buy of ―.
What was Steven Klosk's most profitable transaction?
Steven Klosk’s most profitable transaction was an Informative Buy of CBM stock on June 12, 2018. The return on the trade was 37.50%.
What is Steven Klosk's role in Cambrex?
Steven Klosk's role in Cambrex is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.